Effects of diflunisal on fever in the rabbit and the rat.
The antipyretic efficacy of diflunisal was assessed in rats made febrile by yeast and in rabbits made febrile by bacterial endotoxin. Diflunisal was a more potent antipyretic than aspirin in rats, reducing a maximum fever in doses not producing overt toxic effects. In contrast, submaximal fever in rabbits was not reduced by diflunisal. Fatal hyperthermia of rapid onset was observed in rats and rabbits receiving high doses of diflunisal after administration of microbial pyrogen but not in control animals. These data indicate the toxicity of diflunisal may be potentiated by the presence of pyrogens. It is concluded that the apparent antipyretic efficacy of a drug can depend on the species-pyrogen combination used to screen for antipyresis.
D000818:Animals; D001241:Aspirin / Q000627:therapeutic use; D004061:Diflunisal / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005334:Fever / Q000188:drug therapy*; D008070:Lipopolysaccharides / Q000633:toxicity; D008297:Male; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D012459:Salicylates / Q000627:therapeutic use*; D015003:Yeasts
D008070:Lipopolysaccharides; D012459:Salicylates; D004061:Diflunisal; D001241:Aspirin